194 related articles for article (PubMed ID: 30342510)
1. Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories.
Zaveri T; Powell KA; Guthrie KM; Bakke AJ; Ziegler GR; Hayes JE
BMC Womens Health; 2018 Oct; 18(1):170. PubMed ID: 30342510
[TBL] [Abstract][Full Text] [Related]
2. Shape of vaginal suppositories affects willingness-to-try and preference.
Li B; Zaveri T; Ziegler GR; Hayes JE
Antiviral Res; 2013 Mar; 97(3):280-4. PubMed ID: 23276592
[TBL] [Abstract][Full Text] [Related]
3. Design aspects of vaginal applicators that influence acceptance among target users.
Bakke AJ; Zaveri T; Higgins MJ; Ziegler GR; Hayes JE
Sci Rep; 2021 May; 11(1):9802. PubMed ID: 33963262
[TBL] [Abstract][Full Text] [Related]
4. Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications.
Zaveri T; Running CA; Surapaneni L; Ziegler GR; Hayes JE
Drug Deliv Transl Res; 2016 Oct; 6(5):551-64. PubMed ID: 27357703
[TBL] [Abstract][Full Text] [Related]
5. User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.
Morrow KM; Underhill K; van den Berg JJ; Vargas S; Rosen RK; Katz DF
Arch Sex Behav; 2014 Oct; 43(7):1459-67. PubMed ID: 24452632
[TBL] [Abstract][Full Text] [Related]
6. Designing Dual Compartment HIV Prevention Products: Women's Sensory Perceptions and Experiences of Suppositories for Rectal and Vaginal Use.
Guthrie KM; Rosen RK; Guillen M; Ramirez JJ; Vargas SE; Fava JL; Ham AS; Katz DF; Cu-Uvin S; Tumilty S; Smith KA; Buckheit KW; Buckheit RW
AIDS Res Hum Retroviruses; 2022 Jul; 38(7):601-610. PubMed ID: 34544269
[TBL] [Abstract][Full Text] [Related]
7. Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities.
Hammett TM; Mason TH; Joanis CL; Foster SE; Harmon P; Robles RR; Finlinson HA; Feudo R; Vining-Bethea S; Jeter G; Mayer KH; Doherty-Iddings P; Seage GR
Sex Transm Dis; 2000 Feb; 27(2):119-26. PubMed ID: 10676980
[TBL] [Abstract][Full Text] [Related]
8. Firmness Perception Influences Women's Preferences for Vaginal Suppositories.
Zaveri T; Primrose RJ; Surapaneni L; Ziegler GR; Hayes JE
Pharmaceutics; 2014 Sep; 6(3):512-29. PubMed ID: 25211123
[TBL] [Abstract][Full Text] [Related]
9. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
[No Abstract] [Full Text] [Related]
10. Perceptions of acceptability and utility of microbicides in Ghana, West Africa: a qualitative, exploratory study.
Tanner AE
SAHARA J; 2008 Apr; 5(1):11-8. PubMed ID: 18496615
[TBL] [Abstract][Full Text] [Related]
11. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
[TBL] [Abstract][Full Text] [Related]
12. "Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels.
van den Berg JJ; Rosen RK; Bregman DE; Thompson LA; Jensen KM; Kiser PF; Katz DF; Buckheit K; Buckheit RW; Morrow KM
AIDS Behav; 2014 May; 18(5):862-70. PubMed ID: 24248674
[TBL] [Abstract][Full Text] [Related]
13. Increasing the effectiveness of vaginal microbicides: a biophysical framework to rethink behavioral acceptability.
Verguet S; Young Holt B; Szeri AJ
PLoS One; 2010 Nov; 5(11):e15501. PubMed ID: 21124931
[TBL] [Abstract][Full Text] [Related]
14. Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.
Nel AM; Mitchnick LB; Risha P; Muungo LT; Norick PM
J Womens Health (Larchmt); 2011 Aug; 20(8):1207-14. PubMed ID: 21774672
[TBL] [Abstract][Full Text] [Related]
15. Educating men about vaginal microbicides: considerations from Kenya.
Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
[TBL] [Abstract][Full Text] [Related]
16. Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms.
Weinrib R; Browne EN; Shapley-Quinn MK; van der Straten A; Beksinska M; Mgodi N; Musara P; Mphili N; Schwartz JL; Ju S; Hanif H; Montgomery ET;
AIDS Behav; 2020 Feb; 24(2):637-647. PubMed ID: 31254190
[TBL] [Abstract][Full Text] [Related]
17. Drivers of Vaginal Drug Delivery System Acceptability from Internet-Based Conjoint Analysis.
Primrose RJ; Zaveri T; Bakke AJ; Ziegler GR; Moskowitz HR; Hayes JE
PLoS One; 2016; 11(3):e0150896. PubMed ID: 26999009
[TBL] [Abstract][Full Text] [Related]
18. Vaginal film for prevention of HIV: using visual and tactile evaluations among potential users to inform product design.
Guthrie KM; Rohan L; Rosen RK; Vargas SE; Shaw JG; Katz D; Kojic EM; Ham AS; Friend D; Buckheit KW; Buckheit RW
Pharm Dev Technol; 2018 Mar; 23(3):311-314. PubMed ID: 28592183
[TBL] [Abstract][Full Text] [Related]
19. User preferences in a carrageenan-based vaginal drug delivery system.
Li B; Zaveri T; Ziegler GR; Hayes JE
PLoS One; 2013; 8(1):e54975. PubMed ID: 23358688
[TBL] [Abstract][Full Text] [Related]
20. Women's interest in vaginal microbicides.
Darroch JE; Frost JJ
Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
